Pharmaceutical

Sobi and Enable Injections partner for Aspaveli distribution

Sobi and Enable Injections have entered an agreement for the development and distribution of Aspaveli in combination with enFuse.

Sep 14, 2024 - 04:00
Sobi and Enable Injections partner for Aspaveli distribution
Sobi and Enable Injections have entered an agreement for the development and distribution of Aspaveli in combination with enFuse.
Read the original article

Tags:

Previous Article

Cidara axes 30% of staff to focus on flu prevention drug

Next Article

FDA approves Roche’s Tecentriq Hybreza for cancer

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Opinion: Pharma can’t let Big Tech win the race for medical AI

Opinion: Pharma can’t let Big Tech win the race for med...

Jul 4, 2023

Grit Biotechnology secures funds for development of pipeline programmes

Grit Biotechnology secures funds for development of pip...

Sep 11, 2023

Bayer, short on cash, reaches into shareholders’ pockets

Bayer, short on cash, reaches into shareholders’ pockets

Feb 21, 2024